.Pharmacolibrary.Drugs.ATC.M.M03BA02 .Pharmacolibrary.Drugs.ATC.M.M03BA02| name: | Carisoprodol | |
| ATC code: | M03BA02 | route: | oral |
| compartments: | 1 | |
| dosage: | 350 | mg |
| volume of distribution: | 0.992 | L |
| clearance: | 25.1 | L/h |
| other parameters in model implementation | ||
Carisoprodol is a centrally acting skeletal muscle relaxant that blocks pain sensations between the nerves and the brain. It is primarily used for the short-term relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Carisoprodol is a controlled substance due to its potential for abuse and dependence; in many countries, its use has been reduced or discontinued. In the United States, carisoprodol remains approved for prescription use for up to two or three weeks at a time.
Pharmacokinetic parameters reported in healthy adult volunteers following single oral administration.
Heltsley, R, et al., & Cone, EJ (2011). Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs. Journal of analytical toxicology 35(8) 529–540. DOI:10.1093/anatox/35.8.529 PUBMED:https://pubmed.ncbi.nlm.nih.gov/22004671